insights_auto
Why is INO down ၂.၁၅%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၆၀ US$
arrow_downward
-၂.၁၅%(-၀.၀၃၅) 1D
နို ၁၈, GMT-၅ ၁၀:၅၃:၂၆ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၆၄ US$
High
၁.၆၆ US$
Low
၁.၅၆ US$
Mkt. cap
၂၉.၈၈ ကုဋေ
Avg. vol.
၁.၉၉ ကုဋေ
Volume
၃.၂၁ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
Open
၁.၆၄ US$
High
၁.၆၆ US$
Low
၁.၅၆ US$
Mkt. cap
၂၉.၈၈ ကုဋေ
Avg. vol.
၁.၉၉ ကုဋေ
Volume
၃.၂၁ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၂ နာရီ
Inovio submits European approval application for RRP treatment
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၂ နာရီ
Inovio Pharmaceuticals (INO) Stock Gets Fair Value Boost After VOCERYQ Approval
The Business Journals
·
ပြီးခဲ့သည့် ၁ ရက်
After 43 years, Inovio gets its first FDA-approved drug in 'milestone' decision
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc